← All diseases Muscles and connective tissue

Myotonic dystrophy

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest evidence only (37)Meta-analysis (7)Treatment guideline (7)Systematic review (11)Randomized trial (7)Phase 3 study (5)Clinical trial (148)Review article (142)Early study (phase 1 or 2) (12)Case report (114)Laboratory or animal study (33)Commentary or editorial (59)Retracted publication (1) Studies currently recruiting participants only (33)

Filter

Publications and studies (1161)

• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Development and Clinical Applications of Antisense Oligonucleotide Gapmers. (2020/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Degradation of Toxic RNA in Myotonic Dystrophy Using Gapmer Antisense Oligonucleotides. (2020/01/01) ♡
• Utility and Results from a Patient-Reported Online Survey in Myotonic Dystrophies Types 1 and 2. (2020/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. European Home Mechanical Ventilation Registry (2020-04-09) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical Outcome Measures in Myotonic Dystrophy Type 2 (2020-02-20) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Sleep Breathing Disorders, a Main Trigger for Cardiac Arrhythmias in Type I Myotonic Dystrophy ? (2020-01-18) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Correction of RNA-Binding Protein CUGBP1 and GSK3β Signaling as Therapeutic Approach for Congenital and Adult Myotonic Dystrophy Type 1. (2019/12/21) ♡
• Assessing average somatic CAG repeat instability at the protein level. (2019/12/16) ♡
• Characterization of Iron Accumulation in Deep Gray Matter in Myotonic Dystrophy Type 1 and 2 Using Quantitative Susceptibility Mapping and R2(*) Relaxometry: A Magnetic Resonance Imaging Study at 3 Tesla. (2019/12/13) ♡
• Straightjacket/α2δ3 deregulation is associated with cardiac conduction defects in myotonic dystrophy type 1. (2019/12/12) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models. (2019/12/10) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Strength training and aerobic exercise training for muscle disease. (2019/12/06) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Epidemiological study and genetic characterization of inherited muscle diseases in a northern Spanish region. (2019/12/02) ♡
• Electrodiagnostic findings in myotonic dystrophy: A study on 12 patients. (2019/12/02) ♡
• A study of the impact of DNA helical rise on protein-DNA interaction. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Letter to editor about "Affective symptoms and apathy in myotonic dystrophy type 1: A systematic review and meta-analysis". (2019/12/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Scapular dyskinesis in myotonic dystrophy type 1: clinical characteristics and genetic investigations. (2019/12/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Endurance exercise leads to beneficial molecular and physiological effects in a mouse model of myotonic dystrophy type 1. (2019/12/01) ♡
• Clinical and genetic characteristics of childhood-onset myotonic dystrophy. (2019/12/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. SERUM cardiac-specific biomarkers and atrial fibrillation in myotonic dystrophy type I. (2019/12/01) ♡
• Comparison of Usefulness of Cardiac Resynchronization Therapy in Patients With Type 1 Myotonic Dystrophy With Versus Without Left Bundle Branch Block. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Response to the letter to editor about "Affective symptoms and apathy in myotonic dystrophy type 1 a systematic review and meta-analysis". (2019/12/01) ♡
• Cell-type-specific dysregulation of RNA alternative splicing in short tandem repeat mouse knockin models of myotonic dystrophy. (2019/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Aggressive systemic mastocytosis: a diagnostic challenge in a patient with myotonic dystrophy type 2: a case report. (2019/12/01) ♡
• Arthrogryposis. (2019/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Myotonic Muscular Dystrophies. (2019/12/01) ♡
• Fatigue in myotonic dystrophy type 1: a seven-year prospective study. (2019/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Insulin Signaling as a Key Moderator in Myotonic Dystrophy Type 1. (2019/11/26) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Enhanced serum immunoglobulin G clearance in myotonic dystrophy-associated hypogammaglobulinemia: a case series and review of the literature. (2019/11/20) ♡
• Recovery in the Myogenic Program of Congenital Myotonic Dystrophy Myoblasts after Excision of the Expanded (CTG)n Repeat. (2019/11/13) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. MicroRNA-Based Therapeutic Perspectives in Myotonic Dystrophy. (2019/11/09) ♡
• Paper-like bilateral sternocleidomastoid muscle atrophy may suggest the occurrence of sustained ventricular tachycardia. (2019/11/02) ♡
• Clinical use of bioelectrical impedance analysis in patients affected by myotonic dystrophy type 1: A cross-sectional study. (2019/11/01) ♡
• Assessment of small sensory fiber function in myotonic dystrophy type 1. (2019/11/01) ♡
• Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice. (2019/11/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Better living through peptide-conjugated chemistry: next-generation antisense oligonucleotides. (2019/11/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Overground exoskeletons may boost neuroplasticity in myotonic dystrophy type 1 rehabilitation: A case report. (2019/11/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Targeting myotonic dystrophy by preimplantation genetic diagnosis-karyomapping. (2019/11/01) ♡
• Bioactive Aliphatic Polycarbonates Carrying Guanidinium Functions: An Innovative Approach for Myotonic Dystrophy Type 1 Therapy. (2019/10/21) ♡
• A CTG repeat-selective chemical screen identifies microtubule inhibitors as selective modulators of toxic CUG RNA levels. (2019/10/15) ♡
• Reproductive Cancer Risk Factors in Women With Myotonic Dystrophy (DM): Survey Data From the US and UK DM Registries. (2019/10/11) ♡
• Benefits of combining prevalent and incident cohorts: An application to myotonic dystrophy. (2019/10/01) ♡
• High incidence of falls in patients with myotonic dystrophy type 1 and 2: A prospective study. (2019/10/01) ♡
• Structure of an RNA helix with pyrimidine mismatches and cross-strand stacking. (2019/10/01) ♡
• Myotonic Dystrophy Type 1 Complicated by Colonic Obstruction Due to a Bezoar. (2019/10/01) ♡
• Author response: Consensus-based care recommendations for adults with myotonic dystrophy type 1. (2019/10/01) ♡
• Reader response: Consensus-based care recommendations for adults with myotonic dystrophy type 1. (2019/10/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Consensus-based care recommendations for congenital and childhood-onset myotonic dystrophy type 1. (2019/10/01) ♡
• TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2. (2019/09/27) ♡
• Paving the way for a better understanding of the pathophysiology of gait impairment in myotonic dystrophy: a pilot study focusing on muscle networks. (2019/09/18) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.